Clinical Trials
15 trialsNCT07124000 2026-06-01
DP-04
AstraZeneca
Recruiting
NCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT04314401 2026-05-13
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Active not recruiting
NCT04510129 2025-03-12
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
Recruiting
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT04106167 2023-09-21
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Terminated
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT01040312 2019-05-23
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Daiichi Sankyo
Completed
NCT00477919 2019-05-15
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
Completed
NCT00883181 2017-03-15
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
Amgen
Completed
NCT00310115 2016-09-23
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
M.D. Anderson Cancer Center
Completed
NCT00684801 2015-10-09
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
Case Comprehensive Cancer Center
Completed
NCT00132704 2014-07-24
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Memorial Sloan Kettering Cancer Center
Completed
NCT00433602 2013-06-12
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Completed
NCT00900094 2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed